Aurobindo Pharma Limited engages in manufacturing of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, and internationally. It offers formulation in form of orals, injectables and over-the-counter drugs; and active pharmaceutical ingredients (API) for biosimilars, dermatology, respiratory, vaccines, and peptides, as well as oncology, hormones, and sterile products. The company also provides antiretroviral drugs for the people and children living with HIV; and AuroZymes, a biocatalysts product for use in the pharmaceutical and chemical industries. In addition, it offers AuroSource, a contract services that cover the clinical stage through to manufacturing and management of the entire drug lifecycle in the API space for penicillin's, cephalosporins, and non beta lactams. The company was incorporated in 1986 and is headquartered in Hyderabad, India.

Pay Date	Ex Date	Type	Amount	Amount (Split Adj)
Mar 04, 2024	Feb 20, 2024	Cash	₹1.5	₹1.5
Dec 04, 2023	Nov 20, 2023	Cash	₹3	₹3
Mar 03, 2023	Feb 17, 2023	Cash	₹3	₹3
Jun 15, 2022	Jun 06, 2022	Cash	₹4.5	₹4.5
Mar 04, 2022	Feb 18, 2022	Cash	₹1.5	₹1.5
Nov 30, 2021	Nov 17, 2021	Cash	₹1.5	₹1.5
Sep 07, 2021	Aug 27, 2021	Cash	₹1.5	₹1.5
Mar 04, 2021	Feb 22, 2021	Cash	₹1.5	₹1.5
Dec 04, 2020	Nov 23, 2020	Cash	₹1.25	₹1.25
Sep 04, 2020	Aug 21, 2020	Cash	₹1.25	₹1.25
Mar 02, 2020	Feb 17, 2020	Cash	₹1.75	₹1.75
Dec 04, 2019	Nov 21, 2019	Cash	₹1.25	₹1.25
Feb 28, 2019	Feb 15, 2019	Cash	₹1.25	₹1.25
Nov 30, 2018	Nov 20, 2018	Cash	₹1.25	₹1.25
Feb 28, 2018	Feb 20, 2018	Cash	₹1	₹1

Pay Date	Ex Date	Type	Exchange	Rate
Jul 21, 2015	Jul 20, 2015	Stock dividend	—	2
Feb 10, 2011	Feb 10, 2011	Subdivision	—	5

Aurobindo Pharma Limited

Dividends

Splits